iopamidol has been researched along with Hepatic Encephalopathy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kimura, K; Osaki, A; Sato, M; Takaku, K; Terai, S; Waguri, N; Watanabe, Y; Yamazaki, H; Yamazaki, S | 1 |
1 other study(ies) available for iopamidol and Hepatic Encephalopathy
| Article | Year |
|---|---|
Two cases of portal-systemic encephalopathy caused by multiple portosystemic shunts successfully treated with percutaneous transhepatic obliteration.
Topics: Aged; Enbucrilate; Female; Hepatic Encephalopathy; Humans; Iopamidol; Male; Middle Aged; Portal Vein; Portasystemic Shunt, Transjugular Intrahepatic | 2022 |